Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 1;23(12):1056-1066.
doi: 10.1097/PCC.0000000000003100. Epub 2022 Nov 3.

Pediatric Acute Lung Injury and Sepsis Investigators (PALISI): Evolution of an Investigator-Initiated Research Network

Affiliations

Pediatric Acute Lung Injury and Sepsis Investigators (PALISI): Evolution of an Investigator-Initiated Research Network

Adrienne G Randolph et al. Pediatr Crit Care Med. .

Abstract

The Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network originated over 20 years ago to foster research to optimize the care of critically ill infants and children. Over this period, PALISI has seen two major evolutions: formalization of our network infrastructure and a broadening of our clinical research focus. First, the network is unique in that its activities and meetings are funded by subscriptions from members who now comprise a multidisciplinary group of investigators from over 90 PICUs all over the United States (US) and Canada, with collaborations across the globe. In 2020, the network converted into a standalone, nonprofit organizational structure (501c3), making the PALISI Network formally independent of academic and clinical institutions or professional societies. Such an approach allows us to invest in infrastructure and future initiatives with broader opportunities for fund raising. Second, our research investigations have expanded beyond the original focus on sepsis and acute lung injury, to incorporate the whole field of pediatric critical care, for example, efficient liberation from mechanical ventilator support, prudent use of blood products, improved safety of intubation practices, optimal sedation practices and glucose control, and pandemic research on influenza and COVID-19. Our network approach in each field follows, where necessary, the full spectrum of clinical and translational research, including: immunobiology studies for understanding basic pathologic mechanisms; surveys to explore contemporary clinical practice; consensus conferences to establish agreement about literature evidence; observational prevalence and incidence studies to measure scale of a clinical issue or question; case control studies as preliminary best evidence for design of definitive prospective studies; and, randomized controlled trials for informing clinical care. As a research network, PALISI and its related subgroups have published over 350 peer-reviewed publications from 2002 through September 2022.

PubMed Disclaimer

Conflict of interest statement

Dr. Randolph’s institution received funding from Centers for Disease Control and Prevention (CDC) and National Institute of Allergy and Infectious Diseases, and she received funding from UptoDate. Drs. Randolph and Flori received support for article research from National Institutes of Health (NIH). Dr. Bembea’s institution received funding from the NIH/National Institute of Neurological Disorders and Stroke and Grifols Investigator Sponsored Research Grant. Dr. Cheifetz received funding from Philips, Medtronic, UptoDate, and Tim Peters and Co. Dr. Curley’s institution received funding from National Institute of Child Health and Human Development and National Heart, Lung, and Blood Institute. Dr. Flori’s institution received funding from CDC, Society of Critical Care Medicine, and NIH; she received funding from Aerogen Pharma and Lucira Health; and she disclosed she is an Executive Committee Member for Pediatric Acute Lung Injury and Sepsis Investigators Network. Dr. Khemani received funding from Orange Med and Nihon Kohden. Dr. Nishisaki’s institution received funding from Agency for Healthcare Research and Quality (AHRQ) R03HS026939, AHRQ R18HS024511, and AHRQ R18HS022464, and he received unrestricted grant support by Chiesi, Inc to describe neonatal surfactant administration. Dr. Lacroix’s institution received funding from Canadian Institutes of Health Research. Dr. Thomas received funding from Bayer AG. The remaining authors have disclosed that they do not have any potential conflicts of interest.

Figures

Figure 1.
Figure 1.
Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) network publications published by year from November 27, 2002, to September 20, 2022.
Figure 2.
Figure 2.
Examples of Pediatric Acute Lung Injury and Sepsis Investigators (PALISI)-related websites used to facilitate communication and disseminate evidence, including those of selected PALISI subgroups, special interest groups, and clinical studies. PROSpect = pediatric acute respiratory distress syndrome.

Similar articles

Cited by

References

    1. Guyatt G: Evidence-based medicine. ACP J Club 1991; 114:A-16
    1. Randolph AG, Gonzales CA, Cortellini L, et al. : Growth of pediatric intensive care units in the United States from 1995 to 2001. J Pediatr 2004; 144:792–798 - PubMed
    1. Randolph AG, Lacroix J: Randomized clinical trials in pediatric critical care: Rarely done but desperately needed. Pediatr Crit Care Med 2002; 3:102–106 - PubMed
    1. Randolph AG, Wypij D, Venkataraman ST, et al. : Effect of mechanical ventilator weaning protocols on respiratory outcomes in infants and children: A randomized controlled trial. JAMA 2002; 288:2561–2568 - PubMed
    1. Willson DF, Thomas NJ, Markovitz BP, et al. : Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: A randomized controlled trial. JAMA 2005; 293:470–476 - PubMed

Publication types